ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00765440
Recruitment Status : Completed
First Posted : October 3, 2008
Last Update Posted : February 10, 2015
Sponsor:
Information provided by (Responsible Party):
Centre Antoine Lacassagne

Brief Summary:

RATIONALE: It is not yet known which regimen of enteral nutrition is more effective in preventing infections in patients undergoing surgery for cancer of the upper aerodigestive tract.

PURPOSE: This randomized phase III trial is comparing three nutrition regimens in treating patients with cancer of the upper aerodigestive tract.


Condition or disease Intervention/treatment Phase
Head and Neck Cancer Infection Malnutrition Dietary Supplement: therapeutic nutritional supplementation Other: placebo Phase 3

Detailed Description:

OBJECTIVES:

Primary

  • Determine the efficacy of immunonutrition (IMPACT®) in patients with de novo cancer of the upper aerodigestive tract.

Secondary

  • Determine the best time to initiate treatment.
  • Compare the intermediate duration of treatment.
  • Compare nutritional parameters.

OUTLINE: This is a multicenter study. Patients are randomized to 1 of 3 treatment arms.

  • Arm I: Patients receive standard oral or enteral nutrition (IMPACT® placebo) over 7 days prior to surgery and over 7 days after surgery.
  • Arm II: Patients receive oral or enteral neoadjuvant IMPACT® nutrition over 7 days prior to surgery and enteral adjuvant standard nutrition (IMPACT® placebo) over 7 days after surgery.
  • Arm III: Patients receive oral or enteral IMPACT® nutrition over 7 days prior to surgery and enteral adjuvant IMPACT® nutrition over 7 days after surgery.

After completion of study therapy, patients are followed at 30 days after surgery and then at 2 and 3 months.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 311 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Supportive Care
Official Title: Role of Peri-operative Immunonutrition in Cancers of the Higher Aero-digestive Tract
Study Start Date : July 2007
Actual Primary Completion Date : July 2009
Actual Study Completion Date : April 2011


Arm Intervention/treatment
Placebo Comparator: Arm I
Patients receive standard oral or enteral nutrition (IMPACT® placebo) over 7 days prior to surgery and over 7 days after surgery.
Other: placebo
Given orally
Experimental: Arm II
Patients receive oral or enteral neoadjuvant IMPACT® nutrition over 7 days prior to surgery and enteral adjuvant standard nutrition (IMPACT® placebo) over 7 days after surgery.
Dietary Supplement: therapeutic nutritional supplementation
Given orally
Other: placebo
Given orally
Experimental: Arm III
Patients receive oral or enteral IMPACT® nutrition over 7 days prior to surgery and enteral adjuvant IMPACT® nutrition over 7 days after surgery.
Dietary Supplement: therapeutic nutritional supplementation
Given orally



Primary Outcome Measures :
  1. Rate of infectious complication [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Diagnosis of de novo cancer of the upper aerodigestive tract, including the following:

    • Oral cavity
    • Larynx
    • Oropharynx
    • Hypopharynx
  • Planned surgical excision of tumors with opening of the mucous membranes, with or without immediate reconstruction by myocutaneous pedicle flap or free-bone graft
  • Planned adjuvant enteral nutritional regimen lasting at least 7 days post-operatively

PATIENT CHARACTERISTICS:

  • ANC > 1.8 x 10^9/L
  • Hemoglobin > 9 g/dL
  • Transaminases ≤ 3 times upper limit of normal (ULN)
  • Bilirubin ≤ 3 times ULN
  • Creatinine 70-250 μmol/L
  • Urea ≤ 1.5 times ULN
  • Glucose < 1.5 g/L
  • Sodium < 145 mmol/L
  • Not pregnant or nursing
  • Fertile patients must use effective contraception
  • No psychological, social, geographical, or familial reasons prohibiting follow-up
  • No insulin-dependent diabetes
  • No severe psychiatric illness

PRIOR CONCURRENT THERAPY:

  • No head and neck surgery for cancer within the past year
  • No prior oral components of immunonutrition
  • No prior neoadjuvant chemotherapy
  • No prior radiotherapy to head and neck

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00765440


Locations
France
Centre Antoine Lacassagne
Nice, France, 06189
Sponsors and Collaborators
Centre Antoine Lacassagne
Investigators
Study Chair: Marie-Noelle Falewee Pastor Centre Antoine Lacassagne

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Centre Antoine Lacassagne
ClinicalTrials.gov Identifier: NCT00765440     History of Changes
Other Study ID Numbers: CDR0000599477
First Posted: October 3, 2008    Key Record Dates
Last Update Posted: February 10, 2015
Last Verified: February 2015

Keywords provided by Centre Antoine Lacassagne:
infection
malnutrition
stage I adenoid cystic carcinoma of the oral cavity
stage I mucoepidermoid carcinoma of the oral cavity
stage I verrucous carcinoma of the oral cavity
stage II adenoid cystic carcinoma of the oral cavity
stage II mucoepidermoid carcinoma of the oral cavity
stage II verrucous carcinoma of the oral cavity
stage III adenoid cystic carcinoma of the oral cavity
stage III mucoepidermoid carcinoma of the oral cavity
stage III verrucous carcinoma of the oral cavity
stage IV adenoid cystic carcinoma of the oral cavity
stage IV mucoepidermoid carcinoma of the oral cavity
stage IV verrucous carcinoma of the oral cavity
stage I squamous cell carcinoma of the larynx
stage I verrucous carcinoma of the larynx
stage II squamous cell carcinoma of the larynx
stage II verrucous carcinoma of the larynx
stage III squamous cell carcinoma of the larynx
stage III verrucous carcinoma of the larynx
stage IV squamous cell carcinoma of the larynx
stage IV verrucous carcinoma of the larynx
stage I lymphoepithelioma of the oropharynx
stage I squamous cell carcinoma of the oropharynx
stage II lymphoepithelioma of the oropharynx
stage II squamous cell carcinoma of the oropharynx
stage III lymphoepithelioma of the oropharynx
stage III squamous cell carcinoma of the oropharynx
stage IV lymphoepithelioma of the oropharynx
stage IV squamous cell carcinoma of the oropharynx

Additional relevant MeSH terms:
Head and Neck Neoplasms
Malnutrition
Neoplasms by Site
Neoplasms
Nutrition Disorders